UMMS Affiliation

Program in Molecular Medicine

Date

10-3-2007

Document Type

Article

Subjects

Apoptosis; Gene Products, env; HIV Infections; *HIV-1; Humans; Macrophage Colony-Stimulating Factor; Macrophages; Piperazines; Pyrimidines; Receptors, TNF-Related Apoptosis-Inducing Ligand

Disciplines

Life Sciences | Medicine and Health Sciences

Abstract

Viruses have evolved strategies to protect infected cells from apoptotic clearance. We present evidence that HIV-1 possesses a mechanism to protect infected macrophages from the apoptotic effects of the death ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand). In HIV-1-infected macrophages, the viral envelope protein induced macrophage colony-stimulating factor (M-CSF). This pro-survival cytokine downregulated the TRAIL receptor TRAIL-R1/DR4 and upregulated the anti-apoptotic genes Bfl-1 and Mcl-1. Inhibition of M-CSF activity or silencing of Bfl-1 and Mcl-1 rendered infected macrophages highly susceptible to TRAIL. The anti-cancer agent Imatinib inhibited M-CSF receptor activation and restored the apoptotic sensitivity of HIV-1-infected macrophages, suggesting a novel strategy to curtail viral persistence in the macrophage reservoir.

Rights and Permissions

Citation: PLoS Pathog. 2007 Sep 7;3(9):1281-90. Link to article on publisher's site

DOI of Published Version

10.1371/journal.ppat.0030134

Related Resources

Link to Article in PubMed

Journal Title

PLoS pathogens

PubMed ID

17907802

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.